Podcast on Psychedelics

October 22, 2021 Lynne Nardizzi

Podcast on psychedelics: the science, research, and medical implications with Dr. Fred Barrett.

Dr. Frederick Barrett is a cognitive neuroscientist with training in behavioral pharmacology. He has been conducting psychedelic research at Johns Hopkins University since 2013. He has explored the effects of psilocybin on the brain, the effects of LSD on the brain’s response to music, and is currently leading a number of ongoing studies aimed at better understanding the psychological, biological, and neural mechanisms underlying the therapeutic efficacy of psychedelic drugs.

Psychedelics: Highs and Lows

October 16, 2021 Lynne Nardizzi

There needs to be a bigger conversation on this:

Psychedelics are rapidly achieving the status of breakthrough therapies based on their potential for human development (Nutt, Erritzoe, & Carhart-Harris, 2020; Schenberg, 2018). At the same time, psychedelics may facilitate experiences of distressing or troubling revelations with unexpected or negative consequences to mental health.

MDMA Therapy Revolution

October 13, 2021 Lynne Nardizzi

MAPS Founder and Executive Director Rick Doblin, Ph.D., sits down with Aubrey Marcus to explain MAPS' multiple research, policy, and education priorities in the context of our larger, long-term goal of mass mental health.

"I hope in the big picture, by 2050, we'll have enough people with an understanding of how to use psychedelics for personal, emotional, and spiritual growth that we'll have a more spiritualized humanity to turn us more towards saving the planet from mass weapons, climate change, and prejudice," explains Doblin.

BBC Future profile on Psychedelics

October 10, 2021 Lynne Nardizzi

BBC Future profiles MAPS Founder Rick Doblin, Ph.D., in an extensive article exploring the international impact of psychedelics on science, drug policy, culture, and medicine.

By highlighting the rapid increase in psychedelic research over the past ten years, Ed Prideaux of BBC explains how clinical trial results, favorable media coverage, and the potential development of new mental health treatments are steadily moving the public perception of psychedelics toward mainstream acceptance.

"Now the efforts of Doblin and others are finally paying off,” writes Prideaux. "Promising clinical trials suggest that psychedelics may prove game-changing treatments for depression, PTSD and addiction."

Yale Research on Psilocybin

October 9, 2021 Lynne Nardizzi

Yale researchers discover healing effects of psychedelic drug psilocybin.

Researchers find that one dose of psilocybin results in roughly a 10 percent increase in neuron size and density in mouse brains.

Ketamine and Your Brain

September 13, 2021 Lynne Nardizzi

What does ketamine do to your brain?

Much of how ketamine works is a mystery, but the picture is slowly coming into focus.

Are Doctors Ready for Psychedelics?

September 9, 2021 Lynne Nardizzi

Psychedelic treatments are here, but doctors aren’t prepared.

So says Rick Doblin, founder and executive director of the Multidisciplinary Assn. for Psychedelic Studies.

Evidence on Mushroom Intelligence

September 7, 2021 Lynne Nardizzi

A body of remarkable experiments have shown that fungi operate as individuals, engage in decision-making, are capable of learning, and possess short-term memory.

These findings highlight the spectacular sensitivity of such ‘simple’ organisms, and situate the human version of the mind within a spectrum of consciousness that might well span the entire natural world.